Farmacias similares begins expansion to japan

The mexican pharmacy chain farmacias similares, led by víctor gonzález herrera, has started its expansion strategy to japan through digital marketing and brand adaptation. With 10,000 branches in latin america, the company aims to replicate its generic medicines model in a highly regulated market. This move marks a milestone in its internationalization beyond the american continent.

Farmacias similares, latin america's largest pharmacy chain with 10,000 branches, has solidified its business model focused on generic medicines and adjacent medical consultations. This strategy has driven its growth in mexico and enabled prior explorations in central america.

Now, under the leadership of víctor gonzález herrera, the company is projecting its entry into the japanese market through a focus on digital marketing and social networks. According to the 'de jefes' column published on february 16, 2026, in el financiero, the firm will adapt its corporate identity and emblematic characters, such as doctor simi, under a local japanese aesthetic to connect with asian consumers.

"This growth phase seeks to diversify the group's income and validate the scalability of its generic medicines business model in markets with high regulation and technological demand," the column states.

The japanese pharmaceutical market poses significant challenges, with a highly regulated health system and strong presence of national pharmaceuticals. To enter, farmacias similares would need to comply with regulations from the pharmaceuticals and medical devices agency (pmda) and adapt to the pricing structure of the japanese health system. Sector experts emphasize the need for local alliances, rigorous sanitary certifications, and adaptation to advanced technological standards, given the high entry barriers for imported generic medicines and complex sanitary norms.

This incursion represents an effort to position the brand and the recognition of doctor simi in one of the world's most robust economies, replicating operational success outside the americas.

相关文章

The Chamber of Deputies approved on Monday (2) the bill allowing medicine sales in pharmacies installed inside supermarkets, with rules for physical separation and pharmacist presence. The text, heading to presidential sanction, aims to facilitate access to medicines, especially in remote areas, but faces opposition from some deputies over public health risks.

由 AI 报道

周五东京早盘,日本制药公司股价下跌,此前美国总统唐纳德·特朗普推出提供折扣处方药的网站。住友制药、中外制药和武田制药等主要企业股价下滑,拖累整个制药板块整体表现。特朗普周四宣布与全球16家最大药企达成协议,以最惠国价格换取关税豁免。

中国医疗保健公司正向海外扩展,以服务中东和东南亚地区日益增长的中国侨民社区。Distinct Healthcare计划今年在迪拜开设诊所,而古圣堂集团瞄准东南亚开设50个中心。

由 AI 报道

The cooperative Coopidrogas reported operational revenues of 4.6 trillion pesos in 2025, a 14.6% increase from the previous year. This figure reflects strong performance in the pharmaceutical sector, driven by key categories such as antihypertensives and analgesics. Additionally, the entity expanded its network with a new logistics hub in Galapa.

The Superintendency of Industry and Commerce (SIC) has opened the review of a request for authorization of the business integration between El Market and Globoshops. This operation involves several companies in the commercial sector focused on selling products in tourist areas like airports. The agency invites third parties to submit relevant information within 10 business days.

由 AI 报道

Fernando Savore, vice president of the National Federation and the General Confederation of Grocers, explained on Canal E how consumption in supermarkets and stores has changed due to inflation and digitalization. He noted that large purchases have decreased, favoring small restocks in neighborhood stores. He also highlighted the rise of virtual payments and price adjustments in food.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝